FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309243059> ?p ?o ?g. }

• W4309243059 endingPage "117822182211358" @default.
• W4309243059 startingPage "117822182211358" @default.
• W4309243059 abstract "Background: A greater understanding of Over the Counter (OTC) and Prescription Only Medication (POM) misuse amongst adults accessing substance misuse services (SMS) during COVID-19 is required to identify how SMS can better meet the needs of the people who require treatment. Aim: To use a questionnaire to explore OTC/POM misuse during COVID-19 in adults accessing community SMS in England. Methods: In 2020 to 2021 anonymous self-administered online/paper questionnaires which collated quantitative and qualitative data were completed. They were piloted for suitability and ethical approval was obtained. Thematic analysis was conducted for qualitative data and chi-square tests used to assess the relationship between quantitative variables. Results: Participants were Caucasian (94.6% British), majority male (58.9%), aged 18 to 61 years. Most were prescribed medication for problematic substance use, with a 92.5% self-reported adherence rate. The misuse of benzodiazepines (22.2%) codeine products (30.8%) and pregabalin (14.5%) predominated and 37.5% misused 2 or more medicines. Administration was usually oral and concomitant use of other substances was common: alcohol 44.6% (52% daily), tobacco/vaping 73.2% and illicit substances 58.9%. There were statistically significant associations identified, including between changes during COVID-19 to OTC/POM misuse and illicit use. Only 56 questionnaires were included in the analysis: we believe this low number was because of infection control measures, limited footfall in services, pressures on staff limiting their capacity to distribute the paper questionnaires and reliance upon telephone consultations limiting online distribution. Increasing OTC/POM misuse and obtaining illicit supplies were reported when access to usual supplies were restricted; however, changes to doses/dispensing arrangement liberalisation in response to COVID-19 were positively viewed. Conclusion: OTC/POM misuse, including polypharmacy and concomitant use of other substances occurred during COVID-19: SMS need to be vigilant for these issues and mitigate the associated risks for example with harm reduction interventions. Further qualitative research is required to explore the issues identified." @default.
• W4309243059 created "2022-11-25" @default.
• W4309243059 creator A5025961007 @default.
• W4309243059 creator A5033026095 @default.
• W4309243059 creator A5075349893 @default.
• W4309243059 date "2022-01-01" @default.
• W4309243059 modified "2023-10-18" @default.
• W4309243059 title "Surveying Over the Counter and Prescription Only Medication Misuse in Treatment Services During COVID-19" @default.
• W4309243059 cites W1529367326 @default.
• W4309243059 cites W1594567624 @default.
• W4309243059 cites W1971919047 @default.
• W4309243059 cites W1973180535 @default.
• W4309243059 cites W1975817655 @default.
• W4309243059 cites W1987668599 @default.
• W4309243059 cites W1992988268 @default.
• W4309243059 cites W2012127588 @default.
• W4309243059 cites W2016944872 @default.
• W4309243059 cites W2020291009 @default.
• W4309243059 cites W2043688432 @default.
• W4309243059 cites W2052018177 @default.
• W4309243059 cites W2060201779 @default.
• W4309243059 cites W2065389309 @default.
• W4309243059 cites W2089355683 @default.
• W4309243059 cites W2122838852 @default.
• W4309243059 cites W2123091787 @default.
• W4309243059 cites W2128536774 @default.
• W4309243059 cites W2129660502 @default.
• W4309243059 cites W2151792274 @default.
• W4309243059 cites W2151958035 @default.
• W4309243059 cites W2154495710 @default.
• W4309243059 cites W2158919887 @default.
• W4309243059 cites W2160846242 @default.
• W4309243059 cites W2169888706 @default.
• W4309243059 cites W2614093955 @default.
• W4309243059 cites W2746562707 @default.
• W4309243059 cites W2772896197 @default.
• W4309243059 cites W2891608518 @default.
• W4309243059 cites W2978303387 @default.
• W4309243059 cites W2980382104 @default.
• W4309243059 cites W2990645485 @default.
• W4309243059 cites W3004935511 @default.
• W4309243059 cites W3022725611 @default.
• W4309243059 cites W3048645616 @default.
• W4309243059 cites W3094057429 @default.
• W4309243059 cites W3098081852 @default.
• W4309243059 cites W3125141469 @default.
• W4309243059 cites W3156324838 @default.
• W4309243059 cites W3175311618 @default.
• W4309243059 cites W3175766577 @default.
• W4309243059 cites W3186009275 @default.
• W4309243059 cites W3186135372 @default.
• W4309243059 cites W3205069012 @default.
• W4309243059 cites W4294752518 @default.
• W4309243059 cites W650786253 @default.
• W4309243059 cites W983089324 @default.
• W4309243059 doi "https://doi.org/10.1177/11782218221135875" @default.
• W4309243059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36381425" @default.
• W4309243059 hasPublicationYear "2022" @default.
• W4309243059 type Work @default.
• W4309243059 citedByCount "1" @default.
• W4309243059 crossrefType "journal-article" @default.
• W4309243059 hasAuthorship W4309243059A5025961007 @default.
• W4309243059 hasAuthorship W4309243059A5033026095 @default.
• W4309243059 hasAuthorship W4309243059A5075349893 @default.
• W4309243059 hasBestOaLocation W43092430591 @default.
• W4309243059 hasConcept C118552586 @default.
• W4309243059 hasConcept C126322002 @default.
• W4309243059 hasConcept C127413603 @default.
• W4309243059 hasConcept C144024400 @default.
• W4309243059 hasConcept C159110408 @default.
• W4309243059 hasConcept C170493617 @default.
• W4309243059 hasConcept C188198153 @default.
• W4309243059 hasConcept C190248442 @default.
• W4309243059 hasConcept C2426938 @default.
• W4309243059 hasConcept C2777988657 @default.
• W4309243059 hasConcept C2779134260 @default.
• W4309243059 hasConcept C2779418921 @default.
• W4309243059 hasConcept C2781063702 @default.
• W4309243059 hasConcept C2911204551 @default.
• W4309243059 hasConcept C3008058167 @default.
• W4309243059 hasConcept C36289849 @default.
• W4309243059 hasConcept C512399662 @default.
• W4309243059 hasConcept C524204448 @default.
• W4309243059 hasConcept C71924100 @default.
• W4309243059 hasConcept C74196892 @default.
• W4309243059 hasConcept C78519656 @default.
• W4309243059 hasConceptScore W4309243059C118552586 @default.
• W4309243059 hasConceptScore W4309243059C126322002 @default.
• W4309243059 hasConceptScore W4309243059C127413603 @default.
• W4309243059 hasConceptScore W4309243059C144024400 @default.
• W4309243059 hasConceptScore W4309243059C159110408 @default.
• W4309243059 hasConceptScore W4309243059C170493617 @default.
• W4309243059 hasConceptScore W4309243059C188198153 @default.
• W4309243059 hasConceptScore W4309243059C190248442 @default.
• W4309243059 hasConceptScore W4309243059C2426938 @default.
• W4309243059 hasConceptScore W4309243059C2777988657 @default.
• W4309243059 hasConceptScore W4309243059C2779134260 @default.
• W4309243059 hasConceptScore W4309243059C2779418921 @default.

• next